Setting up a registry and open access genetic testing program for IRDs

“Non‐profit organizations, like the Foundation Fighting Blindness, can play critical roles in helping to catalyze and de‐risk drug development in rare disease spaces like the IRD by a variety of strategies that include incentivizing clinician scientists to commit to these fields, supporting early preclinical and clinical work, sponsoring natural history studies that share data widely, and leveraged investments supporting key proof of concept studies in humans.”

Download the PDF version: Implementation of a registry and open access genetic testing.pdf

or read on the Foundation Fighting Blindness website here: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajmg.c.31825

 

Newsletter

To keep up to date with our news and activities,
please leave your details below

Please indicate your consent for Retina International to contact you via the email address listed for the purposes of general alerts and newsletters.

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.